Aerovate Therapeutics Price Patterns

AVTEDelisted Stock  USD 93.80  0.70  0.75%   
The value of RSI of Aerovate Therapeutics' share price is above 70 at the present time. This suggests that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Aerovate, making its price go up or down.

Momentum 71

 Buy Stretched

 
Oversold
 
Overbought
The successful prediction of Aerovate Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Aerovate Therapeutics and does not consider all of the tangible or intangible factors available from Aerovate Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Aerovate Therapeutics, which may create opportunities for some arbitrage if properly timed.
Using Aerovate Therapeutics hype-based prediction, you can estimate the value of Aerovate Therapeutics from the perspective of Aerovate Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Aerovate Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Aerovate because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Aerovate Therapeutics after-hype prediction price

    
  USD 93.8  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in child.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aerovate Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
77.1277.12103.18
Details
Naive
Forecast
LowNextHigh
94.6194.6194.61
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
92.7693.5494.31
Details

Aerovate Therapeutics After-Hype Price Density Analysis

As far as predicting the price of Aerovate Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aerovate Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Aerovate Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Aerovate Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Aerovate Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aerovate Therapeutics' historical news coverage. Aerovate Therapeutics' after-hype downside and upside margins for the prediction period are 93.80 and 93.80, respectively. We have considered Aerovate Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
93.80
93.80
After-hype Price
93.80
Upside
Aerovate Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Aerovate Therapeutics is based on 3 months time horizon.

Aerovate Therapeutics Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Aerovate Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aerovate Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aerovate Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
7 Events / Month
3 Events / Month
In about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
93.80
93.80
0.00 
0.00  
Notes

Aerovate Therapeutics Hype Timeline

Aerovate Therapeutics is presently traded for 93.80. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Aerovate is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 0.0%. %. The volatility of related hype on Aerovate Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 93.80. About 100.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.02. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aerovate Therapeutics recorded a loss per share of 2.44. The entity last dividend was issued on the 25th of April 2025. The firm had 1:35 split on the 29th of April 2025. Given the investment horizon of 90 days the next anticipated press release will be in about 7 days.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in child.

Aerovate Therapeutics Related Hype Analysis

Having access to credible news sources related to Aerovate Therapeutics' direct competition is more important than ever and may enhance your ability to predict Aerovate Therapeutics' future price movements. Getting to know how Aerovate Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aerovate Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
IGMSIGM Biosciences(0.01)7 per month 2.85  0.05  5.31 (4.84) 21.10 
QNCXQuince Therapeutics(0.12)11 per month 0.00 (0.06) 11.88 (10.66) 120.72 
LABPLandos Biopharma 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
BLIBerkeley Lights 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
NVNOenVVeno Medical Corp(0.95)7 per month 0.00 (0.13) 8.92 (10.09) 41.30 
SURFSurface Oncology 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
IMDXInsight Molecular Diagnostics 0.33 7 per month 4.55  0.01  9.03 (6.67) 22.08 
RPHMReneo Pharmaceuticals 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
MIROMiromatrix Medical 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
ACHLAchilles Therapeutics PLC(0.01)3 per month 0.49  0.17  3.47 (1.74) 22.77 

Aerovate Therapeutics Additional Predictive Modules

Most predictive techniques to examine Aerovate price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aerovate using various technical indicators. When you analyze Aerovate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Aerovate Therapeutics Predictive Indicators

The successful prediction of Aerovate Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aerovate Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aerovate Therapeutics based on analysis of Aerovate Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aerovate Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aerovate Therapeutics's related companies.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in child.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Consideration for investing in Aerovate Stock

If you are still planning to invest in Aerovate Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aerovate Therapeutics' history and understand the potential risks before investing.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Valuation
Check real value of public entities based on technical and fundamental data
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm